Kidney Dysfunction
17
3
4
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.9%
1 terminated out of 17 trials
90.0%
+3.5% vs benchmark
12%
2 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (17)
meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
The Kidney's Response to Exercise in Heat, and the Impact of Vitamin B3 on This Response
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD
Clinical Impact of the IBox As an Early Intervention TooL
A Study of Novel Biomarkers of Kidney Dysfunction at Liver Transplant
Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis
Renal Considerations in the Heat Stress Recommendations
Renal Considerations in the Heat Stress Recommendations (Aim2)
Azilsartan in Patients With Diabetic Kidney Disease and Hypertension
Music Therapy Intervention During Kidney Biopsy.
Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor
Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia
Dynamic Measurement of Renal Functional Reserve as a Predictor of Long-Term Renal Function
Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal Function
The Effects of Decreasing the Lasix Dose on the Cardiorenal System
Shift to Everolimus (RAD) Kidney Sparing Study